Name | 4-[3-chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile |
---|---|
Synonyms |
4-({3-chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl}amino)-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile
MKI-833 4-({3-chloro-4-[(1-methyl-1H-imidazole-2-yl)thio]phenyl}amino)-6-methoxy-7-(4-pyrrolidin-1-ylpiperidin-1-yl)quinoline-3-carbonitrile UNII-7Y0IV7N95Q Balamapimod Balamapimod (USAN) MKI 833 |
Description | MKI 833 (Balamapimod) is a reversible Ras/Raf/MEK inhibitor with potential anti-tumor activity. |
---|---|
Related Catalog | |
Target |
MEK |
References |
Molecular Formula | C30H32ClN7OS |
---|---|
Molecular Weight | 574.13900 |
Exact Mass | 573.20800 |
PSA | 110.77000 |
LogP | 5.88618 |
~% 863029-99-6 |
Literature: Wyeth Patent: US2005/187247 A1, 2005 ; Location in patent: Page/Page column 23 ; US 20050187247 A1 |